Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women

Detalhes bibliográficos
Autor(a) principal: Zoche, Ester
Data de Publicação: 2019
Outros Autores: Bosa, Vera Lúcia, Chaves, Eunice Beatriz Martin, Capp, Edison, Corleta, Helena von Eye
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/216462
Resumo: Introduction: Depression among human immunodeficiency virus (HIV)-seropositive individuals has been associated with reduced quality of life. Objective: To evaluate the effect of depressive symptoms and HIV exposure on mean quality of life scores in HIV-seropositive and HIV-seronegative postpartum women. Methods: A cross-sectional study was conducted with two groups: 80 HIV-seropositive and 80 HIV-seronegative postpartum women. The Edinburgh Postnatal Depression Scale and the World Health Organization Quality of Life short-version scale were used to assess presence of depressive symptoms and quality of life scores. Two-way analysis of variance was used to compare the effects of depressive symptoms, HIV exposure and interaction between depressive symptoms and HIV exposure on mean quality of life scores, with p < 0.05 considered statistically significant. Results: Depressive symptoms were present in 35% (28) of HIV-seropositive and 17.5% (14) of HIV-seronegative participants (p = 0.02). The interaction between depressive symptoms and HIV exposure was not significant for any quality of life domain. The main effect of HIV exposure was also not significant. Depressive symptoms had a negative influence on quality of life scores in all domains (physical health, psychological health, social relationships and environment) (p < 0.001). Conclusion: The quality of life of pregnant women is negatively influenced by the presence of depressive symptoms.
id UFRGS-2_dd74f13fd65b967cae7c54bbd76d3fd7
oai_identifier_str oai:www.lume.ufrgs.br:10183/216462
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Zoche, EsterBosa, Vera LúciaChaves, Eunice Beatriz MartinCapp, EdisonCorleta, Helena von Eye2020-12-11T04:13:47Z20192357-9730http://hdl.handle.net/10183/216462001118496Introduction: Depression among human immunodeficiency virus (HIV)-seropositive individuals has been associated with reduced quality of life. Objective: To evaluate the effect of depressive symptoms and HIV exposure on mean quality of life scores in HIV-seropositive and HIV-seronegative postpartum women. Methods: A cross-sectional study was conducted with two groups: 80 HIV-seropositive and 80 HIV-seronegative postpartum women. The Edinburgh Postnatal Depression Scale and the World Health Organization Quality of Life short-version scale were used to assess presence of depressive symptoms and quality of life scores. Two-way analysis of variance was used to compare the effects of depressive symptoms, HIV exposure and interaction between depressive symptoms and HIV exposure on mean quality of life scores, with p < 0.05 considered statistically significant. Results: Depressive symptoms were present in 35% (28) of HIV-seropositive and 17.5% (14) of HIV-seronegative participants (p = 0.02). The interaction between depressive symptoms and HIV exposure was not significant for any quality of life domain. The main effect of HIV exposure was also not significant. Depressive symptoms had a negative influence on quality of life scores in all domains (physical health, psychological health, social relationships and environment) (p < 0.001). Conclusion: The quality of life of pregnant women is negatively influenced by the presence of depressive symptoms.application/pdfengClinical and biomedical research. Vol. 39, n. 2 (2019), p. 116-121GravidezQualidade de vidaHIVDepressãoPregnancyQuality of lifeDepressionEffect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant womeninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001118496.pdf.txt001118496.pdf.txtExtracted Texttext/plain27742http://www.lume.ufrgs.br/bitstream/10183/216462/2/001118496.pdf.txt4c06dc1bd13048bf181013c2c04f18d8MD52ORIGINAL001118496.pdfTexto completo (inglês)application/pdf773830http://www.lume.ufrgs.br/bitstream/10183/216462/1/001118496.pdf05d4027337067cfa72f911b95bd58634MD5110183/2164622020-12-12 05:21:43.907176oai:www.lume.ufrgs.br:10183/216462Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2020-12-12T07:21:43Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women
title Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women
spellingShingle Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women
Zoche, Ester
Gravidez
Qualidade de vida
HIV
Depressão
Pregnancy
Quality of life
Depression
title_short Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women
title_full Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women
title_fullStr Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women
title_full_unstemmed Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women
title_sort Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women
author Zoche, Ester
author_facet Zoche, Ester
Bosa, Vera Lúcia
Chaves, Eunice Beatriz Martin
Capp, Edison
Corleta, Helena von Eye
author_role author
author2 Bosa, Vera Lúcia
Chaves, Eunice Beatriz Martin
Capp, Edison
Corleta, Helena von Eye
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Zoche, Ester
Bosa, Vera Lúcia
Chaves, Eunice Beatriz Martin
Capp, Edison
Corleta, Helena von Eye
dc.subject.por.fl_str_mv Gravidez
Qualidade de vida
HIV
Depressão
topic Gravidez
Qualidade de vida
HIV
Depressão
Pregnancy
Quality of life
Depression
dc.subject.eng.fl_str_mv Pregnancy
Quality of life
Depression
description Introduction: Depression among human immunodeficiency virus (HIV)-seropositive individuals has been associated with reduced quality of life. Objective: To evaluate the effect of depressive symptoms and HIV exposure on mean quality of life scores in HIV-seropositive and HIV-seronegative postpartum women. Methods: A cross-sectional study was conducted with two groups: 80 HIV-seropositive and 80 HIV-seronegative postpartum women. The Edinburgh Postnatal Depression Scale and the World Health Organization Quality of Life short-version scale were used to assess presence of depressive symptoms and quality of life scores. Two-way analysis of variance was used to compare the effects of depressive symptoms, HIV exposure and interaction between depressive symptoms and HIV exposure on mean quality of life scores, with p < 0.05 considered statistically significant. Results: Depressive symptoms were present in 35% (28) of HIV-seropositive and 17.5% (14) of HIV-seronegative participants (p = 0.02). The interaction between depressive symptoms and HIV exposure was not significant for any quality of life domain. The main effect of HIV exposure was also not significant. Depressive symptoms had a negative influence on quality of life scores in all domains (physical health, psychological health, social relationships and environment) (p < 0.001). Conclusion: The quality of life of pregnant women is negatively influenced by the presence of depressive symptoms.
publishDate 2019
dc.date.issued.fl_str_mv 2019
dc.date.accessioned.fl_str_mv 2020-12-11T04:13:47Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/other
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/216462
dc.identifier.issn.pt_BR.fl_str_mv 2357-9730
dc.identifier.nrb.pt_BR.fl_str_mv 001118496
identifier_str_mv 2357-9730
001118496
url http://hdl.handle.net/10183/216462
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Clinical and biomedical research. Vol. 39, n. 2 (2019), p. 116-121
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/216462/2/001118496.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/216462/1/001118496.pdf
bitstream.checksum.fl_str_mv 4c06dc1bd13048bf181013c2c04f18d8
05d4027337067cfa72f911b95bd58634
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1815447727261089792